SCHEMBL3521038

SCHEMBL3521038

CS(=O)(=O)c1cnc2ccccc2n1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 6/20 0.58
MAPT P10636 3/20 0.58
KMT2A Q03164 1/20 0.58
LMNA P02545 4/20 0.57
ALDH1A1 P00352 3/20 0.57
HPGD P15428 3/20 0.57
SMN1; SMN2 Q16637 2/20 0.56
POLB P06746 1/20 0.55
PKM P14618 1/20 0.55
NPC1 O15118 2/20 0.44
JAK2 O60674 1/20 0.44
RAB9A P51151 1/20 0.44
ALOX15 P16050 1/20 0.44
HSD17B10 Q99714 1/20 0.44
PDE10A Q9Y233 1/20 0.44
KDM4E B2RXH2 2/20 0.43
HSP90AA1 P07900 2/20 0.43
HSP90AB1 P08238 2/20 0.43
GPR3 P46089 1/20 0.41
CYP2C9 P11712 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30665799 0.80 HTT (0.57) HTTMAPTKMT2ALMNAALDH1A1
SCHEMBL3458498 0.80 HTT (0.57) HTTMAPTKMT2ALMNAALDH1A1
SCHEMBL516558 0.80 HTT (0.57) HTTMAPTKMT2ALMNAALDH1A1
Hydrochloric Acid SCHEMBL28203639 0.78 HTT (0.56) HTTMAPTKMT2ALMNAALDH1A1
SCHEMBL27914649 0.78 HTT (0.56) HTTMAPTKMT2ALMNAALDH1A1
SCHEMBL28179002 0.77 ALDH1A1 (0.42) HTTMAPTKMT2ALMNAALDH1A1
SCHEMBL5117540 0.77 HTT (0.54) HTTMAPTKMT2ALMNAALDH1A1
SCHEMBL27767382 0.77 HTT (0.76) HTTMAPTKMT2ALMNAALDH1A1
SCHEMBL11272583 0.77 HTT (0.49) HTTMAPTKMT2ALMNAALDH1A1
SCHEMBL11273237 0.77 HTT (0.49) HTTMAPTKMT2ALMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005089515-A9 METHODS FOR THE TREATMENT OF SYNUCLEINOPATHIES BRIGHAM & WOMENS HOSPITAL (US) 2006-01-26 WO claimed
WO-2005089515-A2 METHODS FOR THE TREATMENT OF SYNUCLEINOPATHIES THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) 2005-09-29 WO claimed
CN-105073758-B Hepatitis c virus inhibitors 吉利德科学公司 2017-08-11 CN disclosed
CN-105073758-A Hepatitis C virus inhibitors GILEAD SCIENCES INC 2015-11-18 CN disclosed
CN-104540832-A Inhibitors of hepatitis C virus GILEAD SCIENCES INC 2015-04-22 CN disclosed
EP-2155197-A2 TREATMENT OF LYSOSOMAL STORAGE DISEASES Link Medicine Corporation (US) 2010-02-24 EP disclosed
WO-2008112525-A2 TREATMENT OF LYSOSOMAL STORAGE DISEASES LINK MEDICINE CORPORATION (US) 2008-09-18 WO disclosed
WO-2005089515-A9 METHODS FOR THE TREATMENT OF SYNUCLEINOPATHIES BRIGHAM & WOMENS HOSPITAL (US) 2006-01-26 WO disclosed
WO-2005089515-A2 METHODS FOR THE TREATMENT OF SYNUCLEINOPATHIES THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) 2005-09-29 WO disclosed
EP-0892797-A4 INHIBITORS OF FARNESYL PROTEIN TRANSFERASE BRISTOL MYERS SQUIBB CO (US) 2004-10-20 EP disclosed
EP-0892797-A1 INHIBITORS OF FARNESYL PROTEIN TRANSFERASE BRISTOL-MYERS SQUIBB COMPANY (US) 1999-01-27 EP disclosed
WO-1997030992-A1 INHIBITORS OF FARNESYL PROTEIN TRANSFERASE BRISTOL-MYERS SQUIBB COMPANY (US) 1997-08-28 WO disclosed